United States · FDA National Drug Code directory
Otrexup
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54436-010_2d07eb50-d314-a6a0-e063-6394a90ac970
- Product NDC
- 54436-010
- Form
- INJECTION, SOLUTION
- Composition / generic term
- methotrexate
- Labeler
- Antares Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131011 / 20270430
Source-listed ingredients
- METHOTREXATE — 10 mg/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (54436-010-01) / .4 mL in 1 SYRINGE · 54436-010-01
- 1 SYRINGE in 1 CARTON (54436-010-03) / .4 mL in 1 SYRINGE · 54436-010-03
- 4 SYRINGE in 1 CARTON (54436-010-04) / .4 mL in 1 SYRINGE (54436-010-02) · 54436-010-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →